These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 122802)

  • 1. Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin.
    Johnston TP; McCaleb GS; Montgomery JA
    J Med Chem; 1975 Jan; 18(1):104-6. PubMed ID: 122802
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T; McMenamin MG; Schein PS
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New streptozotocin analogs with improved antileukemic activity.
    Fujiwara AN; Acton EM; Henry DW
    J Med Chem; 1974 Apr; 17(4):392-6. PubMed ID: 4275387
    [No Abstract]   [Full Text] [Related]  

  • 6. L-Chlorozotocin.
    Johnston TP; McCaleb GS; Anderson T; Murinson DS
    J Med Chem; 1979 May; 22(5):597-9. PubMed ID: 156793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
    Schein PS; Panasci L; Woolley PV; Anderson T
    Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkyl streptozotocin analogues with improved biological activities.
    Iwasaki M; Ueno M; Ninomiya K; Sekine J; Nagamatsu Y
    J Med Chem; 1976 Jul; 19(7):918-23. PubMed ID: 133244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA; Fox P; Schein PS
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
    Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
    Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP; Montgomery JA
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of N,N'-bis(2-chloroethyl)-N-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose upon the proliferation, DNA synthesis, and viability of cultured sensitive and resistant L1210 cells.
    Wheeler GP; Alexander JA; Adamson DJ
    Cancer Res; 1980 Oct; 40(10):3723-7. PubMed ID: 6449283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.
    Panasci LC; Green D; Nagourney R; Fox P; Schein PS
    Cancer Res; 1977 Aug; 37(8 Pt 1):2615-8. PubMed ID: 141323
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of three new nitrosourea analogs (CNCC, RFCNU and chlorozotocin) on in vivo destruction of L 1210 leukemia cells and on the immune response.
    Andrade Mena CE; Orbach-Arbouys S; Cosmatopoulos K; Mathé G
    Chemotherapy; 1986; 32(2):131-7. PubMed ID: 2938892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated N-nitrosocarbamates for regioselective synthesis of N-nitrosoureas.
    Martinez J; Oiry J; Imbach JL; Winternitz F
    J Med Chem; 1982 Feb; 25(2):178-82. PubMed ID: 6460102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP; Schabel FM; Trader MW
    Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of sister-chromatid exchanges in L1210 leukemia cells by new antitumor 2-haloethyl(methylsulfonyl) methanesulfonate compounds.
    Siddiqui KM; Alexander JA; Struck RF
    Mutat Res; 1988; 207(3-4):179-83. PubMed ID: 2833698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.